Azathioprine in the treatment of Crohn's disease.
D001379:Azathioprine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003085:Colic / Q000139:chemically induced; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D008223:Lymphoma / Q000139:chemically induced / Q000150:complications; D010919:Placebos; D011241:Prednisone / Q000627:therapeutic use; D012075:Remission, Spontaneous; D013601:T-Lymphocytes; D013921:Thrombocytopenia / Q000139:chemically induced
D010919:Placebos; D001379:Azathioprine; D011241:Prednisone